MichaelBWohlfeilerMDJ.D.

HIV/AIDS Medicine

Chief Medical Officer, AIDS Healthcare Foundation

Dr. Wohlfeiler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4308 Alton Rd
Ste 870
Miami Beach, FL 33140
Phone+1 305-538-1400

Fax+1 888-972-9651

I am an internist who has specialized in HIV Medicine for 30 years. Since 2013, I have been the Chief Medical Officer for AIDS Healthcare Foundation. AHF is a Los Angeles-based nonprofit organization with a budget of $1.2 billion (in 2017). AHF is the largest provider of HIV/AIDS medical care in the world. Currently, it provides care (regardless of the ability to pay) to almost 850,000 HIV/AIDS patients located in the US and 44 other countries.

As CMO, I have administrative and financial responsibility for the Department of Medicine (domestic) and its associated programs. Those programs include outpatient medical and dental clinics, clinical research, quality improvement, customer service, clinical collaborations with outside entities, the AHF’s HIV Fellowship program, professional development and continuing education for providers and clinical staff.

University of Miami/Jackson Health SystemResidency, Internal Medicine, 1987 - 1990
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1987 - 1988
Rush Medical College of Rush University Medical CenterClass of 1987
University of ArizonaJ.D., Law, 1977 - 1980
University of ArizonaB.A., Political Science, 1972 - 1976

PubMed

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States.
Gerald Pierone, Jennifer S Fusco, Laurence Brunet, Vani Vannappagari, Supriya Sarkar
AIDS Research and Therapy. 2024-10-26
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era.
Michael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Javeed Siddiqui, Michael Harbour
AIDS Research and Human Retroviruses. 2024-07-01
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial.
Michael B Wohlfeiler, Laurence Brunet, Quateka Cochran, Jennifer S Fusco, Ricky K Hsu
Journal of the International Association of Providers of AIDS Care. 2024-04-13

AHF Reminds HIV Patients Care Is ‘Just a Call Away’ During PandemicNovember 20th, 2020
AHF Welcomes ViiV’s Success with Injectable HIV Prevention MedicationMay 20th, 2020
CVS-Aetna Merger: AHF Urges Court to Stop the '800-Pound Gorilla'July 21st, 2019
Join now to see all